Alf Inge L.
- Country
- Norway
- Department
- Cardiovascular Research Stavanger University Hospital
Research Overview
- Prevention of Cardiac Dysfunction with LCZ696 in Early Breast Cancer Patients Receiving Anthracycline-Based Adjuvant Therapy: Randomized Placebo-Controlled Trial (PRADA‑II)
- Phase 2b/3 Randomized Double‑Blind Placebo‑Controlled Trial of Ataciguat to Slow Progression and Improve Peak VO2 in Moderate Calcific Aortic Valve Stenosis
- Efficacy and Safety Evaluation of Subcutaneous Selatogrel in Preventing Recurrent Acute Myocardial Infarction in Post-AMI Patients
Data & Insights
Has run more than one trial at 21 of 327 partner sites.
Specializations
Cardiovascular Medicine
Investigator focuses on acute myocardial infarction, atrial fibrillation, and stroke prevention.
- Acute coronary syndromes
- Antithrombotic strategies in atrial fibrillation
- Ischemic stroke risk reduction
Clinical work emphasizes vascular imaging and biomarker integration.
Neurodegenerative Disorders
Research activity includes Alzheimer’s disease, Amyotrophic Lateral Sclerosis, and dementia with Lewy bodies.
- Early‑stage Alzheimer’s therapeutic evaluation
- Neuroprotective approaches in ALS
- Dementia with Lewy bodies cognitive outcomes
Efforts target disease‑modifying agents and functional assessments.
Oncology
Investigator engages in studies of breast cancer, non‑small cell lung cancer, and multiple myeloma.
- Targeted therapy for HER2‑positive breast cancer
- Immunotherapy combinations in NSCLC
- MRD‑guided treatment in multiple myeloma
Work includes biomarker‑driven trial designs across solid and hematologic malignancies.
Autoimmune & Inflammatory Diseases
Key interests cover rheumatoid arthritis, systemic lupus erythematosus, and hidradenitis suppurativa.
- Therapeutic drug monitoring in rheumatoid arthritis
- Biologic agents for lupus nephritis
- Novel anti‑inflammatory compounds for hidradenitis
Focus is on optimizing biologic regimens and patient‑reported outcomes.
Metabolic & Renal Medicine
Research addresses type 2 diabetes, obesity, and chronic kidney disease.
- Metabolic control in antipsychotic‑treated patients
- Weight management interventions for obesity
- Renal protection strategies in proteinuric kidney disease
Studies integrate endocrine, metabolic, and renal endpoints.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.